| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |